Bhai Parmanand Vidya Mandir Hosts Prestigious Investiture Ceremony

Delhi- Bhai Parmanand Vidya Mandir marked an important achievement in its academic year with the incredible investiture ceremony. The newly elected student council took the oath of office and promised to defend the institution’s ideals and principles at the occasion, which was marked by passion and a sense of responsibility.

 The ceremony began with a formal march past, which highlighted the children’s discipline and dedication. The Chief Guest and the academic leaders of the school awarded badges and sashes to the deserving students, symbolizing their responsibility as the school’s representatives. The occasion served as proof of the best school in east Delhi Bhai Parmanand Vidya Mandir’s, dedication to helping its students develop completely and as leaders.

 In her address, Academic Director Pratibha Sharma highlighted the significance of leadership, responsibility, and service, adding, “At Bhai Parmanand Vidya Mandir, the top school of east Delhi we believe in developing future leaders who will not only excel academically but also lead with ethics and compassion. Our students are recognized and provided the confidence to assume these important responsibilities within the school community through the investiture ceremony.

 The ceremony ended with a vote of thanks, leaving the audience impressed by the students’ leadership and ability to take on new tasks. Bhai Parmanand Vidya Mandir continues its legacy of developing future leaders by combining moral principles with academic excellence.

Study Abroad: UK & USA count in top destination choices for Mumbai students

Mumbai, 20 August 2024: LeapScholar in association with GeeBee Education is organising a study abroad fair in Mumbai. Renowned universities from the USA, UK, Canada, Ireland, Australia, New Zealand & Europe will be participating in the education fair, allowing students to discover top universities of their choice and know more about desired programs. The Mumbai event is scheduled to take place at Hotel Sahara Star on Sunday, 25th August 2024 from 10 am – 4 pm.

The event will offer spot offers, application fee waivers, and scholarships for eligible students, along with on-spot counselling from university experts to guide students and parents in choosing the right path for their study abroad journey. Complemented by participation from the US consulate as well as value-added services such as loans, GIC FOREX, and more for all attendees.

With over 300 universities and colleges participating, more than 4000+ students and parents are expected to attend. Aspirants will be able to avail spot admissions and scholarship opportunities after on-site assessments of academic profile. Some of the top participating universities across countries include Northern Arizona University, Northwest Missouri State University, Ohio University, Queen Mary University of London, University of Leeds, University of York, Cardiff Metropolitan University, Leeds Beckett University, Niagara College Canada, Fairleigh Dickinson University, Vancouver, Auckland University of Technology, University of Auckland, Paris School of Business, Berlin School of Business and Innovation GmbH, etc.

“In recent years, there has been a noticeable increase in the number of student applicants from Mumbai seeking global education. At GeeBee, our mission is to provide students with a seamless pathway to international universities, having already assisted over 250,000 students to broaden their horizons. With this education fair, we aim to offer students an opportunity to personally meet the representatives of various international universities. The event will also feature participation from the US consulate, including a seminar for both aspiring students and parents.” stated Mayank Gupta, Chief Operating Officer, GeeBee Education.

Some of the popular destination preferences of students from Maharashtra wanting to go abroad include countries like the USA, UK, Canada, Ireland, Australia, New Zealand, Europe, etc. Most applications received from the state are for postgraduate degrees in Global Business, Marketing, Engineering, Data Science, Business Analytics among others.

MAHE signs MOU with SKAN and Happiest Health for academics, research and consultancy

Bengaluru, 20 August 2024: SKAN Research Trust (SKAN), promoted by Indian entrepreneur Ashok Soota, today announced that Happiest Health and SKAN have signed an MOU with Manipal Academy of Higher Education (MAHE) for academics, research and consultancy.

The projects for joint collaborative research will include microbiome studies, stem cell research, and biotherapeutics. MAHE will use its vast experience to provide consultancy to facilitate Happiest Health’s setting up various healthcare practices.

Mr. Ashok Soota, Chairman & Managing Trustee of SKAN, said, “We are delighted that Manipal Academy of Higher Education (MAHE) has agreed to sign an agreement covering R&D and Academic collaboration with SKAN and also an agreement to provide consultancy to Happiest Health for various healthcare practices. MAHE is a powerhouse with vast years of experience in academics, research, and multiple healthcare practices. We look forward to advancing the frontiers of science through collaborative research with them.”

Lt. Gen. (Dr.) M. D. Venkatesh, VSM (Retd.), Vice Chancellor of Manipal Academy of Higher Education, added, “This partnership aligns with our vision of fostering innovation and cutting-edge research. At MAHE, we have always emphasized the importance of advancing healthcare through rigorous academic inquiry and pioneering research. With our strong foundation in research, particularly in areas like molecular biology, biotechnology, and clinical research, we are excited to collaborate with SKAN and Happiest Health. This partnership not only enhances our capabilities but also allows us to contribute significantly to impactful research in emerging fields like microbiome studies and stem cell therapies, areas where MAHE has been actively involved. We look forward to leveraging our strengths to drive innovations that will transform healthcare practices.”

Dr. Sharath Rao, Pro Vice Chancellor of Manipal Academy of Higher Education, stated, “This MOU marks a significant step in our journey of collaborative research and academic excellence. MAHE has a rich history of academic rigor and innovation, and we are proud of our strong research culture, which has produced significant contributions to healthcare and science. Our expertise in microbiome studies, combined with our interdisciplinary approach and state-of-the-art facilities, positions us well to partner with SKAN and Happiest Health in pushing the boundaries of scientific knowledge. We are confident that this collaboration will lead to meaningful advancements, not only in healthcare but also in the way research is conducted, ultimately benefiting society at large.”

Dr. Yogesh Shouche, Director, SKAN, said “We will quickly begin dialogue with MAHE to define specific research projects. SKAN would like to expand its expertise in gut microbiome to cover other human microbiome components.”

Understanding Xanthophobia and Its Effects

By-Dr. Himanshu Nirvan, MBBS, MD (Psychiatry), Department of Psychiatry, Noida International Institute of Medical Sciences (NIIMS) College & Hospital

Xanthophobia is an irrational fear of the colour yellow. It arises when someone feels a fear of something or a situation associated with this particular colour. This condition is also known by other names, such as fear of yellow or yellow phobia. People with xanthophobia get extremely anxious or experience panic attacks when they see or come into contact with anything yellow. An intense, unanticipated feeling of fear and anxiety is called a panic attack. Breathlessness, anxiety, and chest discomfort are possible side effects. Although the precise etiology of xanthophobia is unknown, a mix of psychological, environmental, and genetic variables are thought to be responsible.

Several main factors can contribute to the development of xanthophobia. These include a family history of anxiety disorders, a traumatic experience involving the colour yellow, excessive stress or anxiety, and substance abuse. All of these elements could make xanthophobia more likely to manifest. It’s crucial to remember, though, that having these risk factors does not guarantee that a person will experience this phobia.

The types and intensity of xanthophobia symptoms differ from person to person. Along with physical symptoms like sweating, shaking, a fast heartbeat, or shortness of breath, common symptoms include intense dread or anxiety when viewing yellow or yellow items. Because of this phobia, the sufferer may try to stay away from settings where yellow could be present, which can make someone’s every single day a challenge.

Psychiatrists and psychologists are mental health specialists who diagnose xanthophobia based on the patient’s symptoms, medical history, and private information. Clinical interviews, psychological evaluations, and physical examinations might all be part of this assessment. To guarantee an accurate diagnosis, it is crucial to rule out other potential explanations of symptoms that are comparable.

The treatment of xanthophobia typically involves a combination of therapy and medication. Common treatments include Cognitive-Behavioral Therapy (CBT), exposure therapy, and medications like antidepressants or anti-anxiety drugs. CBT helps individuals identify and change negative thoughts and behaviours. Exposure therapy gradually introduces the person to the colour yellow to reduce their fear over time. Medications can help control anxiety and panic symptoms.

There’s no guaranteed way to prevent xanthophobia, but some strategies can help reduce the risk. These include getting timely treatment for anxiety or other mental health disorders, avoiding traumatic experiences related to the colour yellow, practising healthy coping skills and stress-management techniques, and using relaxation methods such as deep breathing or meditation. These measures can improve mental health and lower the chances of developing xanthophobia.

With proper treatment, most people with xanthophobia can learn to manage their fear and anxiety, improving their quality of life. However, without treatment, the fear can become more severe and disruptive, interfering more with daily life. Timely treatment and support can help overcome this fear and enhance the quality of life. Xanthophobia is a serious mental condition, but it can be overcome with the right treatment and support. If you or a loved one shows symptoms of this phobia, it’s important to consult a mental health professional. With timely treatment and support, this fear can be managed, and life can improve.

Godrej Properties launches a first-of-its-kind initiative; WhereTrustResides

Mumbai, August 20, 2024

Godrej Properties Limited (GPL), a leading real estate developer in India, recently announced the launch of its visionary campaign, #WhereTrustResides. Given that home buying is one of the most significant milestones in an individual’s life, consumers often look at brands that have stood as a testament to time and legacy. While elevated lifestyle, designer homes, and premium amenities are on the rise in the list of what consumers seek today, the top priority remains the same – trust.

The journey of home buying is surrounded by ambiguity and uncertainty, and Godrej Properties believes that there is both a huge need and a responsibility to give credence to this feeling, be it by simplifying the world of real estate or by educating consumers about the right things to look out for at various stages of this journey. To do so, the brand took a first-of-its-kind approach by introducing a 9-year-old character – Diya.

As part of the campaign, the brand has released a digital video featuring ‘Diya’, a curious and uninhibited mind who embodies the collective consciousness of today’s home buyers – be it their joyful explorations, nervous excitement, or outright apprehensions. The storyline uses an unfiltered lens to narrate Diya’s quest to explore the world of real estate which starts with her parents buying a Godrej home. While the brand has her parents’ trust, her trust is a little more difficult to win. With a head full of curiosity, a heart full of optimism, and a mind devoid of any filters, she sets out to find out whether the Godrej can be her dream home. Through her journey, Godrej Properties aims to resolve the concerns of home buyers thereby fuelling the trust people place on the category – #WhereTrustResides

In just the first tranche of the campaign, Diya’s innocent curiosity has already garnered over 100 million views across social media platforms like Instagram, Facebook, YouTube, and LinkedIn.

Speaking about the campaign, Lalit Makhijani, Chief Marketing Officer at Godrej Properties Ltd., said, “At Godrej Properties, we recognize the significant impact that trust plays in the home-buying journey. Through #WhereTrustResides and Diya’s explorations, our objective is to create a platform that echoes home buyers’ voices to ensure a transparent and stress-free journey for them. This campaign resonates with our dedication to building enduring relationships with our homebuyers founded on trust and excellence”.

The build-up of the campaign began with intriguing videos of various stakeholders at Godrej Properties prepping up for Diya’s arrival. And just when there was enough speculation around ‘who’s Diya’ a vending machine mysteriously appeared on Friendship Day across different Godrej Properties premises in India. Diya befriended 4,500 people from Godrej family and shared not just moments and chocolates but her thoughts around her Godrej Ghar too.

NMDC Hyderabad Marathon 2024: India’s 2nd Largest Marathon and World Athletics Label Race

Hyderabad, August 20, 2024: Hyderabad Runners Society, NMDC & IDFC FIRST Bank together with the Govt. of Telangana announced the 13th edition of the annual NMDC Hyderabad Marathon 2024 powered by IDFC FIRST Bank. The run will have over 25,500 participants including a couple of thousand from all over India and participants from 17 countries to run in this prestigious City Marathon. The annual sporting extravaganza is gaining massive appeal among serious and amateur runners across India and overseas.

World Athletics Label: NMDC Hyderabad Marathon 2024 powered by IDFC FIRST Bank has applied to World Athletics, and after meeting all the criteria has been awarded the World Athletics Label. So, the 13th Edition of the Hyderabad Marathon is officially a World Athletics Label Race. We have invited Elite Runners from overseas and we are looking forward to a new course record being set in this edition.

The finishers Medal and T-Shirt was unveiled by Shri. Amitava Mukherjee, The Chairman and Managing Director (Addl Charge) & Director Finance, NMDC Ltd, and Shri. Nirish Lalan, Head Branch Banking South, IDFC FIRST Bank, Ms.Nikhat Zareen the face of the event, Race Director Shri Rajesh Vetcha and other sponsors graced the occasion.

Event Programme :

23rd – Expo at HITEX,
24th – 5k at HITEX and expo at HITEX
25th – 10K, Half and Full

The event days are the 24th and 25th August 2024. The 5K, a curtain raiser will be held on 24th August at 7 a.m. at Hitex. On 25th August the runs will be flagged-off as follows: Full Marathon at 4:30 a.m., Half Marathon and 5:30 a.m. (from People Plaza, Necklace Road) & 10K Run at 7.00 a.m. from Hitex, Madhapur.

The marathon route will traverse the important landmarks in the city giving the runners a picturesque view of the Hussain Sagar Lake, Raj Bhavan Road, KBR Park, Jubilee Hills Road No. 45, Durgam Cheruvu Cable Bridge, Bio-diversity Junction, University of Hyderabad and finishes at Gachibowli Stadium, while spreading the healthy lifestyle theme among Hyderabad citizens. The 10K Run will be starting from Hitex Grounds and will merge with the Half and Full Marathon route near IKEA Circle and will finish at Gachibowli Stadium.

Speaking on the occasion, Mr. Rajesh Vetcha, Race Director, NMDC Hyderabad Marathon 2024, said, “Hyderabad Runners Society is proud to lead the active lifestyle movement and the 13th edition of the Marathon is a step in that direction with the World Athletics Label placing it on the international running calendar. This year, we have seen a growth in the number of participants to about 25,500, coming from almost 30 states and UTs as well as international Elite Athletes participation. We are eager to make them experience world class race facilities on this World Athletics Label Race. The Prize money across all categories is about ₹ 48 lakhs”

We are also proud to support runners from many NGOs, who are working with different under-privileged sections of the society and have also facilitated fund raising for 13 Charity organizations under the aegis of the NMDC Hyderabad Marathon 2024 powered by IDFC FIRST Bank.

This marathon is more than just a race; it is also providing a platform to 13 of our charity partners to raise funds and create awareness. As of now, our fundraising efforts propelled close to 1985 donors, 185 individual fundraisers, 869 charity bibs and 8 corporates fund raising, which helped in raising funds to the tune of ₹75,98,673/- as of 20th August, 2024 and this will continue till 30th September, 2024 and we hope to achieve our target of Rs.2 Crores. These contributions help us to make a positive impact on our community. Your participation helps support various charitable causes, making every step you take and every donation you make even more meaningful.

We call out to all sections of the society to support this initiative and make Hyderabad the health capital of the country. We thank the Govt of Telangana, the City Police and our Sponsors for their backing in this active lifestyle movement.”

MGM Cancer Institute’s Anamaya Program: A New Hope for Children with Blood Disorders and Cancers

CHENNAI, Aug. 20, 2024 — MGM Cancer Institute proudly announces the launch of the Anamaya Program, a groundbreaking initiative aimed at helping children lead a disease-free life, starting with thalassemia. Thalassemia, a genetic condition affecting hemoglobin in red blood cells, has a significant presence in South India.

Through the Anamaya Program, MGM Cancer Institute has conducted extensive screening and awareness programs across Tamil Nadu and Andhra Pradesh, including tribal communities. Over the past six months, the institute has screened around 5,000 children for thalassemia and other blood disorders. The institute’s efforts have identified approximately 25 children with thalassemia, who are now being brought to MGM Cancer Institute for further evaluation and treatment in association with Saptha Foundation (A NGO which supports treatment of Thalassemia in children). The treatment expenses will be supported through funds from the government, NGOs, and concessions provided by the hospital.

In Andhra Pradesh and Tamil Nadu alone, approximately 10,000 individuals are affected by thalassemia major, contributing to the larger national count of nearly 100,000 patients. If untreated, this condition drastically reduces life expectancy, with most children not surviving beyond age 15 due to frequent blood transfusions and iron overload in vital organs such as the heart and liver. Currently, bone marrow transplantation (BMT) is the only permanent cure for thalassemia, allowing children to lead normal lives post-treatment.

Addressing thalassemia’s impact involves improving access to screening and care, enhancing healthcare infrastructure, and investing in research for novel treatments like gene therapy. A comprehensive strategy, including prevention programs and robust data collection, is essential for managing this disease effectively.

At the MGM Cancer Institute, the Department of Pediatric Hematology and Oncology offers holistic care for children, adolescents, and young adults with hemoglobinopathies. The institute’s mission is to treat these children by understanding their special needs and providing them with comprehensive, compassionate care from diagnosis through recovery.

Speaking about the program, Dr M Deenadayalan, HOD and Clinical Lead, Paediatric Haematology, Oncology, Blood and Marrow Transplantation, said, “Thalassemia is a significant public health concern in India, especially in the southern regions. National surveys indicate beta-thalassemia shows a notable prevalence, with carrier rates estimated at around 3-4% nationwide. However, these rates can surge up to 17% within certain communities, particularly those with high consanguinity or among tribal populations.”

He further added, “This program will be a bridge to the existing gap of uneven access to screening, identifying, and treating thalassemia, other blood disorders and cancers in children. As phase one of the program, our focus will be on thalassemia, which requires lifelong medical care, imposing a strain on the children and families. A multi-pronged approach is necessary, strengthening carrier screening, prenatal diagnosis, and genetic counselling, along with improved healthcare infrastructure and trained professionals.”

Speaking during the event Dr. M A Raja, Director, Oncology Services, MGM Cancer Institute, said, “Thalassemia is a disease diagnosed between birth and two years, and approximately 15000 babies are born in India every year with this. It is an inherited condition, and we in India have the highest number of thalassemia cases in the world. Proper screening and counseling can help to reduce the incidence of this disease because marriage among close relatives who are carriers without disease can give birth to babies with disease. Once a diagnosis is made, standard treatment is only repeated blood transfusions and supportive care. However, this is not curative and can cause heart failure, liver toxicity, and premature deaths. The ONLY curative option is a bone marrow transplant. MGM Cancer Institute is well equipped to offer this treatment to many unfortunate children affected by this disease. Our hospital with expert hematologists and well-trained nurses will help to transform the lives of such children by offering a permanent cure. We will continue your conduct camps for screening, early detection, and counseling in vulnerable populations.”

In addition to thalassemia, the program will extend its screening efforts to other childhood cancers and blood disorders, ensuring early detection and treatment for those in need. MGM Cancer Institute is committed to making a lasting impact in the fight against these conditions, one child at a time.

The Anamaya program was launched in the presence of Dr. M A Raja, Director, Oncology Services, MGM Cancer Institute; Dr. Ananth Mohan Pai Director – Medical Services, MGM Healthcare; Mr. Siva, COO, MGM Cancer Institute and Dr. Vimal Kumar G and Dr. Rishab Bharadwaj from the Paediatric Haematology, Oncology, Blood and Marrow Transplantation department.